logo

For the Inventor, By the Inventor

Chicago, IL, United States of America

Xeris Pharmaceuticals, Inc.


USPTO Granted Patents = 25



Trademarks = 8

Forward Citations = 149

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Steven J Prestrelski (21 out of 24 patents)

silverMedal John Kinzell (6 out of 6 patents)

bronzeMedal Martin J Donovan (6 out of 24 patents)

4.  Michael A Sandoval (5 out of 6 patents)

5.  Nancy Scott (3 out of 3 patents)

6.  Kevin J Brodbeck (3 out of 7 patents)

7.  Brian R Sloat (2 out of 4 patents)

8.  Wendy Hu (2 out of 2 patents)

9.  Fredric Cohen (1 out of 12 patents)

10.  Wei-Jie Fang (1 out of 1 patent)

11.  John Frank Carpenter (1 out of 31 patents)

12.  Evan Cassavaugh (1 out of 1 patent)


25 patents:

1. 12377096 - Methods of treating disease with levoketoconazole (2025-08-05),
2. 11964003 - Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the same (2024-04-23),
3. 11957736 - Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same (2024-04-16),
4. 11833157 - Precipitation resistant small molecule drug formulations (2023-12-05),
5. 11590205 - Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents (2023-02-28),
6. 11576951 - Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same (2023-02-14),
7. 11446310 - Stable formulations for parenteral injection of small molecule drugs (2022-09-20),
8. 11129940 - Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes (2021-09-28),
9. 11020403 - Precipitation resistant small molecule drug formulations (2021-06-01),
10. 10987399 - Stable formulations for parenteral injection of peptide drugs (2021-04-27),
11. 10765683 - Stable formulations for parenteral injection of small molecule drugs (2020-09-08),
12. 10485850 - Methods for producing stable therapeutic formulations in aprotic polar solvents (2019-11-26),
13. 9687527 - Stable glucagon formulations for the treatment of hypoglycemia (2017-06-27),
14. 9649364 - Methods for producing stable therapeutic formulations in aprotic polar solvents (2017-05-16),
15. 9642894 - Compositions for rapidly treating severe hypoglycemia (2017-05-09),
Xeris Pharmaceuticals, Inc. is a specialty pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with serious, acute, and life-threatening diseases. With an emphasis on endocrinology and rare diseases, Xeris aims to improve patient care by offering easier-to-use, ready-to-use liquid formulations of approved drugs. These formulations have the potential to eliminate the need for reconstitution, thus enhancing safety, convenience, and adherence. Xeris is committed to advancing novel treatments that leverage its proprietary formulation technology across various therapeutic areas.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
25 Patents

#159 in Chicago, IL

#669 in Illinois

#12,934 in US

#24,953 in the World

...
Chicago, IL, United States of America

Xeris Pharmaceuticals, Inc.

Forward Citations = 149

12 inventors:

goldMedal Steven J Prestrelski (21 out of 24 patents)

silverMedal John Kinzell (6 out of 6 patents)

bronzeMedal Martin J Donovan (6 out of 24 patents)

4.  Michael A Sandoval (5 out of 6 patents)

5.  Nancy Scott (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com
Loading…